Claudia Matter Selected Research

A-factor (Streptomyces)

1/2015

Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claudia Matter Research Topics

Disease

4	Melanoma (Melanoma, Malignant) 01/2020 - 08/2010
3	Neoplasms (Cancer) 11/2013 - 08/2010
1	Carcinogenesis 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2013
1	Inflammation (Inflammations) 01/2013
1	Skin Neoplasms (Skin Cancer) 01/2013
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2013
1	Testicular Neoplasms (Testicular Cancer) 08/2010

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2013
2	SOXE Transcription FactorsIBA 01/2020 - 01/2015
2	AntigensIBA 11/2013 - 08/2010
2	Peptides (Polypeptides)IBA 11/2013 - 08/2010
1	glycogen synthase kinase 3 alphaIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	CateninsIBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	A-factor (Streptomyces)IBA 01/2015
1	Interleukin-2 (IL2)IBA 11/2013
1	CyclinsIBA 11/2013
1	Cyclin D1IBA 11/2013
1	Interleukin-10 (Interleukin 10)IBA 03/2013
1	Immunoglobulins (Immunoglobulin)IBA 03/2013
1	CytokinesIBA 03/2013
1	Nitric Oxide Synthase (NO Synthase)IBA 03/2013
1	Fibronectins (Fibronectin)IBA 03/2013
1	Interferon Regulatory FactorsIBA 03/2013
1	Mucin-3IBA 03/2013
1	Imiquimod (Aldara)FDA LinkGeneric 01/2013
1	Toll-Like Receptor 7IBA 01/2013
1	InflammasomesIBA 01/2013
1	Interleukin-1 (Interleukin 1)IBA 01/2013
1	AntibodiesIBA 08/2010
1	VaccinesIBA 08/2010

Therapy/Procedure

2	Immunotherapy 11/2013 - 08/2010